CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Best Funds Ask the Mole Best Places to Retire Big Tech Blog Techland Blog Sectors and Stocks Fortune 500 Techs Tech Talk 100 Best Places to Launch Ultimate Resource Guide Small Biz Makeovers FSB 100 Ask & Answer Fortune 500 Technology Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts

Antidepressants may not work - report

Antidepressant drugs may have little effect on patients, many unpublished studies show.

Subscribe to Companies
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)

drug_bottles.03.jpg
Anti-depressants may not be as effective as patients -- and doctors -- believe.

NEW YORK (CNNMoney.com) -- Patients and doctors alike may have received some fuzzy truth about the effectiveness of antidepressant medication.

According to a report in The Wall Street Journal, many studies have found that best-selling antidepressants like Wyeth's Effexor and Pfizer's Zoloft may have little or even no effect on patients. Many of those studies, though submitted to the Food and Drug Administration, were left unpublished.

Researchers accordingly suggested in this week's New England Journal of Medicine that doctors and patients may not have been able to see the full antidepressant picture.

Both Pfizer (PFE, Fortune 500) and Wyeth (WYE, Fortune 500) told The Wall Street Journal that they will disclose all study results, but they will not necessarily publish them in medical journals. The FDA does not require pharmaceutical companies to publish the studies that they sponsor, which leaves many studies unpublished.

Separately, 74 studies involving 12 antidepressant drugs were submitted to the FDA between 1987 and 2004, 38 of which the FDA called "positive." Though all but one of the "positive" studies were published, only 14 of the 36 "negative" studies were printed in medical journals.

But even with the large disparity of reports that the pharmaceutical companies published, not all of the negative stories were all that "negative."

According to the NEJM researchers, at least 11 of the 14 "negative" studies presented unfavorable findings as beneficial ones by highlighting positive secondary outcomes and ignoring negative primary results.

The New England Journal of Medicine researchers believe this "publication bias" can complicate doctors' understanding of the effectiveness of medications. For instance, when considering all of the studies' data, the researchers found that Zoloft only has a "small" effect on patients as opposed to the "medium" effect that the mostly-positive results had shown.  To top of page

Photo Galleries
The best credit card for you All credit cards are not created equal. Here are a few we like. More
New Jaguar XJ: Tata's luxury flagship Jaguar rolls out a new top-of-the-line luxury sedan -- the finishing touch on a troubled brand's make-over. More
Cyber-bureaucracy in India An intrepid entrepreneur looks to make millions bringing e-governance to India's remote villages. More
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.